Teva Pharmaceutical Industries Ltd (TEVA) — Cash Flow Reinvestment Rate
Teva Pharmaceutical Industries Ltd (TEVA) has a Cash Flow Reinvestment Rate of 0.54x as of March 2026, reinvesting ILA167.56 Million (capex ILA167.56 Million ) from operating cash flow of ILA313.17 Million. Check TEVA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Teva Pharmaceutical Industries Ltd Cash Flow Reinvestment Rate (1991–2025)
Historical reinvestment intensity for Teva Pharmaceutical Industries Ltd across 34 annual periods. Explore TEVA long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year capital reinvestment analysis for Teva Pharmaceutical Industries Ltd. For live market cap and broader valuation context, see Teva Pharmaceutical Industries Ltd (TEVA) total market value.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | ILA557.32 Million | ILA3.10 Billion | ILA542.32 Million | ▼ -57.6% |
| 2024 | 0.42x | ILA529.00 Million | ILA1.25 Billion | ILA498.00 Million | ▼ -57.4% |
| 2023 | 0.99x | ILA1.36 Billion | ILA1.37 Billion | ILA526.00 Million | ▲ +187.1% |
| 2022 | 0.35x | ILA551.00 Million | ILA1.59 Billion | ILA548.00 Million | ▼ -59.7% |
| 2021 | 0.86x | ILA687.00 Million | ILA798.00 Million | ILA562.00 Million | ▲ +68.6% |
| 2020 | 0.51x | ILA621.00 Million | ILA1.22 Billion | ILA578.00 Million | ▲ +119.8% |
| 2019 | 0.23x | ILA125.00 Million | ILA538.00 Million | ILA119.00 Million | ▼ -26.2% |
| 2018 | 0.31x | ILA770.00 Million | ILA2.45 Billion | ILA651.00 Million | ▲ +2.8% |
| 2017 | 0.31x | ILA1.07 Billion | ILA3.51 Billion | ILA874.00 Million | ▼ -95.6% |
| 2016 | 7.01x | ILA36.64 Billion | ILA5.22 Billion | ILA901.00 Million | ▲ +1300.5% |
| 2015 | 0.50x | ILA2.77 Billion | ILA5.54 Billion | ILA772.00 Million | ▲ +104.9% |
| 2014 | 0.24x | ILA1.25 Billion | ILA5.13 Billion | ILA929.00 Million | ▼ -33.6% |
| 2013 | 0.37x | ILA1.19 Billion | ILA3.24 Billion | ILA1.03 Billion | ▲ +52.4% |
| 2012 | 0.24x | ILA1.10 Billion | ILA4.57 Billion | ILA1.10 Billion | ▼ -5.2% |
| 2011 | 0.25x | ILA1.05 Billion | ILA4.13 Billion | ILA1.05 Billion | ▲ +48.4% |
| 2010 | 0.17x | ILA710.00 Million | ILA4.14 Billion | ILA710.00 Million | ▼ -19.5% |
| 2009 | 0.21x | ILA719.00 Million | ILA3.37 Billion | ILA719.00 Million | ▲ +1.1% |
| 2008 | 0.21x | ILA681.00 Million | ILA3.23 Billion | ILA681.00 Million | ▼ -29.5% |
| 2007 | 0.30x | ILA542.00 Million | ILA1.81 Billion | ILA542.00 Million | ▲ +57.8% |
| 2006 | 0.19x | ILA390.00 Million | ILA2.06 Billion | ILA390.00 Million | ▼ -16.3% |
| 2005 | 0.23x | ILA310.10 Million | ILA1.37 Billion | ILA310.10 Million | ▼ -9.1% |
| 2004 | 0.25x | ILA311.00 Million | ILA1.25 Billion | ILA311.00 Million | ▼ -24.8% |
| 2003 | 0.33x | ILA207.50 Million | ILA626.60 Million | ILA207.50 Million | ▼ -27.0% |
| 2002 | 0.45x | ILA160.40 Million | ILA353.70 Million | ILA160.40 Million | ▼ -7.6% |
| 2001 | 0.49x | ILA134.07 Million | ILA273.15 Million | ILA134.07 Million | ▼ -9.1% |
| 2000 | 0.54x | ILA89.42 Million | ILA165.63 Million | ILA89.42 Million | ▲ +23.6% |
| 1999 | 0.44x | ILA67.07 Million | ILA153.61 Million | ILA67.07 Million | ▼ -77.4% |
| 1998 | 1.93x | ILA135.60 Million | ILA70.20 Million | ILA135.60 Million | ▲ +489.8% |
| 1997 | 0.33x | ILA63.40 Million | ILA193.60 Million | ILA63.40 Million | ▼ -69.3% |
| 1995 | 1.07x | ILA112.60 Million | ILA105.40 Million | ILA112.60 Million | ▼ -48.7% |
| 1994 | 2.08x | ILA79.50 Million | ILA38.20 Million | ILA79.50 Million | ▲ +73.2% |
| 1993 | 1.20x | ILA45.30 Million | ILA37.70 Million | ILA45.30 Million | ▲ +24.1% |
| 1992 | 0.97x | ILA27.30 Million | ILA28.20 Million | ILA27.30 Million | ▼ -60.5% |
| 1991 | 2.45x | ILA22.30 Million | ILA9.10 Million | ILA22.30 Million | — |